Annaly Capital Management, Inc. Reports 1st Quarter 2022 Results
NEW YORK–(BUSINESS WIRE)–Annaly Capital Management, Inc. (NYSE: NLY) (“Annaly” or the “Company”) today announced its…
News
Invitation Homes Reports First Quarter 2022 Results
DALLAS–(BUSINESS WIRE)–Invitation Homes Inc. (NYSE: INVH) (“Invitation Homes” or the “Company”), the nation’s premier single-family…
TriState Capital Reports First Quarter 2022 EPS of $0.48 on New Record Levels of Net Interest Income, Revenue and Loans, With Continued Net Interest Margin Expansion
— Organic growth of commercial loans, private banking loans primarily backed by marketable securities, and…
Molina Healthcare Reports First Quarter 2022 Financial Results
Increases Full-Year 2022 Revenue and Earnings Guidance LONG BEACH, Calif.–(BUSINESS WIRE)–$MOH–Molina Healthcare, Inc. (NYSE: MOH)…
United Rentals Announces Record First Quarter Results and Raises 2022 Guidance for Revenue, Adjusted EBITDA and Both Operating and Free Cash Flow
STAMFORD, Conn.–(BUSINESS WIRE)–United Rentals, Inc. (NYSE: URI) today announced financial results for the first quarter…
Getty Realty Corp. Announces First Quarter 2022 Results
– Increases 2022 Annual Guidance – NEW YORK–(BUSINESS WIRE)–Getty Realty Corp. (NYSE: GTY) (“Getty” or…
Coursera Reports First Quarter 2022 Financial Results
Revenue grows 36% year-over-year Platform surpasses 100 million total registered learners MOUNTAIN VIEW, Calif.–(BUSINESS…
Clarus Therapeutics Announces Closing of Upsized $30.0 Million Underwritten Public Offering
NORTHBROOK, Ill., April 27, 2022 (GLOBE NEWSWIRE) — Clarus Therapeutics Holdings, Inc. (Clarus) (Nasdaq:CRXT), a…
Veza, the Data Security Company Built On The Power of Authorization, Emerges from Stealth and Announces $110 Million in Funding
The company fills a gaping hole in data security: authorization — the ability to understand,…
Gardner Companies Announces Changes in Leadership
Founder Kem C. Gardner to transition into Chairman Emeritus. Son, Christian, to operate as Chairman…
ERI Partners with Call2Recycle and CellBlock FCS for Innovative Battery Collection Solution, OneDrum
FRESNO, Calif.–(BUSINESS WIRE)–#ERI–Last week on Earth Day, Call2Recycle, the country’s first and largest consumer battery…
Metropolitan Cuts Outdoor Watering to One Day a Week for Six Million Southern Californians
Restriction aims to immediately reduce water use in communities with supplies severely limited by state…
Altada Launches ‘AI Possible’ Summit
Leader in AI-powered Decision-Making to Hold First-Ever Thought Leadership Event CORK, Ireland & NEW YORK…
Procore Appoints Joy Durling as Chief Data Officer
CARPINTERIA, Calif.–(BUSINESS WIRE)–Procore Technologies, Inc. (NYSE: PCOR), a leading global provider of construction management software,…
Proficio Launches New Service to Protect Enterprises from Identity-based Attacks and Credentials Abuse
Identity Threat Detection and Response powered by ProSOC MDR and Active Defense XDR CARLSBAD, Calif.,…
Ayala Pharmaceuticals Announces Poster Presentation on AL101 at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
REHOVOT, Israel and WILMINGTON, Del., April 27, 2022 (GLOBE NEWSWIRE) — Ayala Pharmaceuticals, Inc. (Nasdaq:…
PMV Pharmaceuticals to Present PC14586 Phase 1 Clinical Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Oral presentation at ASCO to highlight initial data from ongoing Phase 1 study of PC14586,…
Steve DeAngelo and Andrew DeAngelo Join Harvest Direct’s Advisory Board
Cannabis reform activists bring their experience and advocacy roots to progress and innovate cannabis formulations…
LAVA Therapeutics to Present Updated LAVA-051 Clinical Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
UTRECHT, The Netherlands and PHILADELPHIA, April 27, 2022 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (Nasdaq:…
PDS Biotech Announces Two Abstracts Accepted for Presentation at the 2022 American Society of Clinical Oncology Annual Meeting
Preliminary efficacy and safety update on PDS0101 in combination with KEYTRUDA® (pembrolizumab) in first-line recurrent…